Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Buy
52
NTRA Quote, Financials, Valuation and Earnings
Last price:
$160.41
Seasonality move
:
-0.91%
Day range:
$157.27 - $161.15
52-week range:
$58.53 - $175.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.73x
P/B ratio:
24.08x
Volume:
655.5K
Avg. volume:
1.3M
1-year change:
161.78%
Market cap:
$21.2B
Revenue:
$1.1B
EPS (TTM):
-$1.76
Analysts' Opinion
-
Consensus RatingNatera has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $167.90, Natera has an estimated upside of 4.77% from its current price of $160.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $37.00 representing 100% downside risk from its current price of $160.26.
Fair Value
-
According to the consensus of 12 analysts, Natera has 4.77% upside to fair value with a price target of $167.90 per share.
NTRA vs. S&P 500
-
Over the past 5 trading days, Natera has overperformed the S&P 500 by 0.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Natera does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Natera has grown year-over-year revenues for 30 quarters straight. In the most recent quarter Natera reported revenues of $439.8M.
Earnings Growth
-
Natera has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Natera reported earnings per share of -$0.26.
Enterprise value:
20.6B
EV / Invested capital:
16.54x
Price / LTM sales:
12.73x
EV / EBIT:
--
EV / Revenue:
13.45x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-471.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$883.4M
Return On Assets:
-14.38%
Net Income Margin (TTM):
-14.01%
Return On Equity:
-26.45%
Return On Invested Capital:
-18.26%
Operating Margin:
-8.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $776M | $988.7M | $1.5B | $268.3M | $439.8M | |
| Gross Profit | $352.9M | $422.8M | $883.4M | $121M | $271.7M | |
| Operating Income | -$538.9M | -$503.5M | -$242.1M | -$111M | -$39.3M | |
| EBITDA | -$520.9M | -$465.5M | -$169.8M | -$98.6M | -$19.5M | |
| Diluted EPS | -$5.69 | -$4.52 | -$1.76 | -$0.95 | -$0.26 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $916M | $1.2B | $829.6M | $1.3B | $1.3B | |
| Total Assets | $976.7M | $1.3B | $1B | $1.4B | $1.6B | |
| Current Liabilities | $195.9M | $199.7M | $267.3M | $289.9M | $301.4M | |
| Total Liabilities | $440.7M | $552.4M | $647.5M | $661.9M | $712.4M | |
| Total Equity | $536M | $759M | $361.6M | $784.7M | $878.5M | |
| Total Debt | $250M | $330.1M | $331.5M | $363.1M | $367M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$449.1M | -$270.5M | $25.2M | -$29.7M | $51.8M | |
| Cash From Investing | $387.9M | $166.3M | $172.9M | $81.3M | $42.5M | |
| Cash From Financing | $23M | $715.8M | $26.1M | $236M | $1.7M | |
| Free Cash Flow | -$494M | -$311.5M | -$43.7M | -$38.7M | $25M | |
NTRA
Sector
Market Cap
$21.2B
$45.9M
Price % of 52-Week High
91.25%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
161.78%
-32.15%
Beta (5-Year)
1.628
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$160.98
200-day SMA
Buy
Level
$118.59
Bollinger Bands (100)
Buy
Level
115.31 - 155.95
Chaikin Money Flow
Buy
Level
87.6M
20-day SMA
Sell
Level
$165.72
Relative Strength Index (RSI14)
Buy
Level
50.05
ADX Line
Sell
Level
18.86
Williams %R
Neutral
Level
-65.0584
50-day SMA
Buy
Level
$149.29
MACD (12, 26)
Buy
Level
1.95
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
77.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.9131)
Sell
CA Score
(Annual)
Level (-1.4209)
Buy
Beneish M-Score
(Annual)
Level (-3.0032)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.3856)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier’s children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Stock Forecast FAQ
In the current month, NTRA has received 12 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NTRA average analyst price target in the past 3 months is $167.90.
-
Where Will Natera Stock Be In 1 Year?
According to analysts, the consensus estimate is that Natera share price will rise to $167.90 per share over the next 12 months.
-
What Do Analysts Say About Natera?
Analysts are divided on their view about Natera share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Natera is a Sell and believe this share price will drop from its current level to $37.00.
-
What Is Natera's Price Target?
The price target for Natera over the next 1-year time period is forecast to be $167.90 according to 12 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NTRA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Natera is a Buy. 12 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTRA?
You can purchase shares of Natera via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Natera shares.
-
What Is The Natera Share Price Today?
Natera was last trading at $160.41 per share. This represents the most recent stock quote for Natera. Yesterday, Natera closed at $160.26 per share.
-
How To Buy Natera Stock Online?
In order to purchase Natera stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
